Policy | August 27, 2025
GST rejig may impact competitiveness of medical devices: AiMeD
AiMeD noted that proposed GST changes—to either 5% or 18%—both present significant risks requiring carefully nuanced consideration
AiMeD noted that proposed GST changes—to either 5% or 18%—both present significant risks requiring carefully nuanced consideration
Abbott's investigational Coronary Intravascular Lithotripsy (IVL) System offers a new potential treatment by using sound pressure waves to treat arterial calcium blockages
Unfortunate to see PM’s ‘Make in India’ dream being bulldozed
Medical Device Policy is a progressive step in propelling the country towards Atmanirbharta in the heavily import dependent Medical Device Sector
The Niti Aayog and the DoP had listed a few factors that were leading to a 10-15% disability factor to be globally competitive
India imported medical devices worth Rs. 63,200 crore in 2021-22, up 41% from Rs. 44,708 crore in 2020-21
The deal reinforces GSK’s leadership in respiratory care and builds upon the company’s expanding COPD portfolio
Basketball legend, entrepreneur, and entertainer Shaquille O’Neal partners with Lilly to encourage Americans to recognize the signs of obstructive sleep apnea and talk to their
Contera Pharma will receive an upfront payment and full research funding for each target under investigation
New test expands access to early Alzheimer’s assessment, streamlining diagnostic pathways and improving referral efficiency
Subscribe To Our Newsletter & Stay Updated
